NANCY P CARAWAY to Urinary Bladder Neoplasms
This is a "connection" page, showing publications NANCY P CARAWAY has written about Urinary Bladder Neoplasms.
Connection Strength
0.630
-
Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study. Cancer Cytopathol. 2010 Oct 25; 118(5):259-68.
Score: 0.149
-
A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis. Cancer Cytopathol. 2010 Aug 25; 118(4):175-83.
Score: 0.148
-
Combination of cytologic evaluation and quantitative digital cytometry is reliable in detecting recurrent disease in patients with urinary diversions. Cancer. 2007 Oct 25; 111(5):323-9.
Score: 0.121
-
Use of mailed urine specimens in diagnosing urothelial carcinoma by cytology and DNA image analysis. Acta Cytol. 2005 Mar-Apr; 49(2):157-62.
Score: 0.101
-
Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior. Sci Rep. 2017 01 19; 7:40714.
Score: 0.058
-
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res. 2008 Jan 01; 14(1):224-9.
Score: 0.031
-
Centrosomal abnormality is common in and a potential biomarker for bladder cancer. Int J Cancer. 2003 Sep 20; 106(5):661-5.
Score: 0.023